#monkeypox samples

Monkeypox is a rare zoonotic infection caused by the Monkeypox virus. It is an orthopoxvirus infection with symptoms similar to those of smallpox. Monkeypox virus often affects nonhuman primates like monkeys or rodents like rats or mice. However, the infection can pass to humans as well. Usually, symptoms of monkeypox start 5 to 21 days after exposure to the virus. This is called the incubation period of the disease. The signs and symptoms of monkeypox include fever, skin rash, chills, myalgia, back pain, fatigue, and swollen lymph nodes. The skin rashes begin 1 to 4 days after your fever first appears. Monkeypox rash starts on the face, hands, or legs and spreads to other body parts. Rashes appear to be flat in the earlier stages of illness and later develop into blisters filled with pus, and scabs fall off over two to four weeks. In 2022, the monkeypox outbreak was reported in different non-endemic countries like the United States, the United Kingdom, and parts of Europe. Due to the recent incidence of the disease and increasing monkeypox cases, it has been declared a Public Health Emergency of International Concern (PHEIC). At the same time, health authorities have alarmed scientists worldwide to ramp up research for discovering potent vaccines and treatments to curb the disease outbreak.

Central BioHub welcomes Suppliers for Monkeypox Samples.

As we have seen in this period of the widespread pandemic, banked human biospecimens from COVID-19 patients have considerably fuelled COVID-19 research worldwide. It is an essential source for developing COVID-19 vaccines and a more accurate COVID-19 diagnostic tool. It was a perfect example to demonstrate the importance of human biospecimens in contemporary medical research. The need for high-quality, well-annotated human bio samples for research is, therefore, enormous. Consequently, there is a sizable demand for high-quality, well-annotated human biosamples for clinical investigations today.